Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ERGAMISOL TAB 50MG DIN 00846368

Status: Cancelled Post Market
Holder: JANSSEN INC
Molecule: LEVAMISOLE (LEVAMISOLE HYDROCHLORIDE)

Health Canada record

Active ingredient(s)LEVAMISOLE (LEVAMISOLE HYDROCHLORIDE) 50 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCP02CE01 LEVAMISOLE
Original market date31-Dec-1990
Current status date17-Oct-2003
SourceHealth Canada DPD

Establishment licence of the holder

Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LEVAMISOLE (LEVAMISOLE HYDROCHLORIDE)

DINProductCompanyFormStrengthStatus
02234217NOVO-LEVAMISOLENOVOPHARM LIMITEDTabletLEVAMISOLE (LEVAMISOLE HYDROCHLORIDE) 50 MGCancelled Post Market
01951912SPARTAKON TAB 20MGWILDLIFE LABORATORIES, INC.TabletLEVAMISOLE (LEVAMISOLE HYDROCHLORIDE) 20 MGCancelled Post Market
00658251VERMI-GAIN 42 TRAMISOL(PORCS ET BOVINS)OLIER GRISE ET CIE LTEEPowderLEVAMISOLE (LEVAMISOLE HYDROCHLORIDE) 800 MGCancelled Post Market
Request a quote for ERGAMISOL TAB 50MG

How to read a Canadian DIN record